Compare BLCO & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | OUT |
|---|---|---|
| Founded | 1853 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.8B |
| IPO Year | 2022 | 2013 |
| Metric | BLCO | OUT |
|---|---|---|
| Price | $15.80 | $33.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $18.45 | ★ $28.50 |
| AVG Volume (30 Days) | 469.3K | ★ 1.5M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | ★ $5,101,000,000.00 | $1,831,700,000.00 |
| Revenue This Year | $8.65 | $6.19 |
| Revenue Next Year | $5.59 | $3.08 |
| P/E Ratio | ★ N/A | $304.09 |
| Revenue Growth | ★ 6.47 | 0.04 |
| 52 Week Low | $11.22 | $15.45 |
| 52 Week High | $18.92 | $34.96 |
| Indicator | BLCO | OUT |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 64.25 |
| Support Level | $15.67 | $31.14 |
| Resistance Level | $16.41 | $34.96 |
| Average True Range (ATR) | 0.38 | 1.07 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 18.00 | 58.82 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.